US FDA approves Innoviva's oral antibiotic for common sexually transmitted infections

Core Viewpoint - The U.S. Food and Drug Administration has approved Innoviva's oral antibiotic for treating a common sexually transmitted infection, providing a pill alternative to the currently available injection treatment [1] Company Summary - Innoviva has developed an oral antibiotic that has received FDA approval, marking a significant advancement in the treatment options for sexually transmitted infections [1] Industry Summary - The approval of an oral antibiotic by the FDA represents a shift in the treatment landscape for sexually transmitted infections, potentially increasing patient compliance and accessibility compared to injection-based therapies [1]